Two grants from the National Institutes of Health will allow Saint Louis
University researchers to build on breakthroughs in understanding the
hepatitis B virus and begin the search for a drug to cure – not just
halt – the illness.
Last year, John Tavis, Ph.D., professor of molecular microbiology and
immunology at SLU published research demonstrating a way to measure and
then block a previously unstudied enzyme, RNAseH, to stop the virus
from replicating.
Armed with that knowledge, Tavis now has the early data and funding
to begin the search for a drug that may help to cure patients with
hepatitis B.
Read more.... Labels: Research and Discoveries, RNAseH